The effect of tyrosine kinase inhibitor genistein on voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells

Vascular Pharmacology

Volumn 50, Issue 1-2, 2009, Pages 51-56

  Ko, Eun A ^a   Park, Won Sun ^a   Son, Youn Kyoung ^b   Kim, Do Hyung ^a   Kim, Nari ^a   Kim, Hyoung Kyu ^a   Choi, Tae Hoon ^c   Jung, In Duk ^d   Park, Yeong Min ^d   Han, Jin ^a  

^a Inje University College of Medicine   (South Korea)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c Andong Science College   (South Korea)

^d Pusan National University   (South Korea)

Author keywords

Coronary arterial smooth muscle cells; Genistein; Protein tyrosine kinase; Voltage dependent K+ channel

Indexed keywords

ADENOSINE TRIPHOSPHATE; DAIDZEIN; GENISTEIN; GENISTIN; PROTEIN TYROSINE KINASE; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; NONHUMAN; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE FIBER;

ANIMALS; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENISTEIN; ION CHANNEL GATING; ION TRANSPORT; MYOCYTES, SMOOTH MUSCLE; PATCH-CLAMP TECHNIQUES; PHOSPHORYLATION; POTASSIUM; POTASSIUM CHANNELS, VOLTAGE-GATED; PROTEIN KINASE INHIBITORS; RABBITS;

EID: 57249103324     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2008.09.004     Document Type: Article

References (42)

1. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., and Itoh N. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 25 (1987) 5592-5595
2. Barnes S., and Peterson T.G. Biochemical targets of the isoflavone genistein in tumor cell lines. Proc. Soc. Exp. Med. Biol. 208 (1995) 103-108
3. Barnes S., Peterson T.G., and Coward L. Use of genistein-containing soy matrices in chemoprevention trials for breast and prostate cancer. J. Cell. Biochem. 22 (1995) 181-187
4. Chang K.L., Kung M.L., Chow N.H., and Su S.J. Genistein arrests hepatoma cells at G2/M phase: involvement of ATM activation and upregulation of p21waf1/cip1 and Wee1. Biochem. Pharmacol. 67 (2004) 717-726
5. Chiang C.E., Chen S.A., Chang M.S., Lin C.I., and Luk H.N. Genistein directly inhibits L-type calcium currents but potentiates cAMP-dependent chloride currents in cardiomyocytes. Biochem. Biophys. Res. Commun. 223 (1996) 598-603
6. Cho H., Youm J.B., Earm Y.E., and Ho W.K. Inhibition of acetylcholine-activated K(+) current by chelerythrine and bisindolylmaleimide I in atrial myocytes from mice. Eur. J. Pharmacol. 424 (2001) 173-178
7. Choi B.H., Choi J.S., Jeong S.W., Hahn S.J., Yoon S.H., and Jo Y.H. Direct block by bisindolylmaleimide of rat Kv1.5 expressed in Chinese hamster ovary cells. J. Pharmacol. Exp. Ther. 293 (2000) 634-640
8. Choi B.H., Park J.H., and Hahn S.J. Open channel block of Kv3.1 currents by genistein, a tyrosine kinase inhibitor. Korean J. Physiol. Pharmacol. 10 (2006) 71-77
9. Choi J., Choi B.H., Hahn S.J., Yoon S.H., Min D.S., and Jo Y. Inhibition of Kv1.3 channels by H-89 (N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide) independent of protein kinase A. Biochem. Pharmacol. 61 (2001) 1029-1032
10. Choi J.S., Hahn S.J., Rhie D.J., Jo Y.H., and Kim M.S. Staurosporine directly blocks Kv1.3 channels expressed in Chinese hamster ovary cells. Naunyn Schmiedeberg's Arch. Pharmacol. 359 (1999) 256-261
11. Dixon R.A., and Ferreira D. Genistein. Phytochemistry 60 (2002) 205-211
12. Dubois J.M., and Rouzaire-Dubois B. Role of potassium channels in mitogenesis. Prog. Biophys. Mol. Biol. 59 (1993) 1-21
13. Gao Z., Lau C.P., Wong T.M., and Li G.R. Protein tyrosine kinase-dependent modulation of voltage-dependent potassium channels by genistein in rat cardiac ventricular myocytes. Cell. Signal. 16 (2004) 333-341
14. Huang X.Y., Morielli A.D., and Peralta E.G. Tyrosine kinase-dependent suppression of a potassium channel by the G protein-coupled m1 muscarinic acetylcholine receptor. Cell 75 (1993) 1145-1156
15. Illek B., Fischer H., and Machen T.E. Alternate stimulation of apical CFTR by genistein in epithelia. Am. J. Physiol. 270 (1996) C265-275
16. Illek B., Fischer H., Santos G.F., Widdicombe J.H., Machen T.E., and Reenstra W.W. cAMP-independent activation of CFTR Cl channels by the tyrosine kinase inhibitor genistein. Am. J. Physiol. 268 (1995) C886-893
17. + currents of rat mesenteric arterial smooth muscle. Eur. J. Pharmacol. 483 (2004) 117-126
18. Kim H., Peterson G., and Barnes S. Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor β signaling pathway. Am. J. Clin. Nutr. 68 (1998) 1418S-1425S
19. + channels in vascular smooth muscle cells. J. Smooth Muscle Res. 44 (2008) 65-81
20. Korovkina V.P., and England S.K. Molecular diversity of vascular potassium channel isoforms. Clin. Exp. Pharmacol. Physiol. 29 (2002) 317-323
21. Liu H., Li K., and Sperelakis N. Tyrosine kinase inhibitor, genistein, inhibits macroscopic L-type calcium current in rat portal vein smooth muscle cells. Can. J. Physiol. Pharmacol. 75 (1997) 1058-1062
22. + channels by staurosporine. Am. J. Physiol. 266 (1994) C1128-1132
23. MerzDemlow B.E., Duncan A.M., Wangen K.E., Xu X., Carr T.P., and Phipps W.R. Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women. Am. J. Clin. Nutr. 71 (2000) 1462-1469
24. Nelson M.T., and Quayle J.M. Physiological roles and properties of potassium channels in arterial smooth muscle. Am. J. Physiol. 268 (1995) C799-822
25. 2+ current in guinea pig ventricular myocytes treated with modulators of tyrosine phosphorylation. Am. J. Physiol. 276 (1999) H1724-1733
26. + current through a PKC-independent mechanism in isolated coronary arterial smooth muscle cells. J. Cardiovasc. Pharmacol. 45 (2005) 260-269
27. + channels in coronary arterial smooth muscle cells. Life Sci. 77 (2005) 512-527
28. ATP and Kir channels in rabbit coronary arterial smooth muscle cells. Biochem. Biophys. Res. Commun. 340 (2006) 1104-1110
29. + current by H-89 in rabbit coronary arterial smooth muscle cells. Vascul. Pharmacol. 46 (2007) 105-113
30. + channel gating in mouse Schwann cells. J. Physiol. 519 (1999) 373-384
31. Peterson T.G. Evaluation of the biochemical targets of genistein in tumor cells. J. Nutr. 125 (1995) 784S-789S
32. + currents by tyrosine kinase inhibitors genistein and ST 638. Circ. Res. 76 (1995) 310-316
33. Snyders D.J., and Yeola S.W. Determinants of antiarrhythmic drug action. Electrostatic and hydrophobic components of block of the human cardiac hKv1.5 channel. Circ. Res. 77 (1995) 575-583
34. Sobey C.G. Potassium channel function in vascular disease. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 28-38
35. V channels in rabbit coronary arterial smooth muscle cells. Biochem. Biophys. Res. Commun. 341 (2006) 931-937
36. Sorota S. Tyrosine protein kinase inhibitors prevent activation of cardiac swelling-induced chloride current. Pflügers Arch. 431 (1995) 178-185
37. Su S.J., Chow N.H., Kung M.L., Hung T.C., and Chang K.L. Effects of soy isoflavones on apoptosis induction and G2-M arrest in human hepatoma cells involvement of caspase-3 activation, Bcl-2 and Bcl-XL downregulation, and Cdc2 kinase activity. Nutr. Cancer 45 (2003) 113-123
38. Su S.J., Yeh T.M., Chuang W.J., Ho C.L., Chang K.L., and Cheng H.L. The novel targets for antiangiogenesis of genistein on human cancer cells. Biochem. Pharmacol. 69 (2005) 307-318
39. + channels in regulating tumour cell proliferation and apoptosis. Pflügers Arch. 448 (2004) 274-286
40. Washizuka T., Horie H., Obayashi K., and Sasayama S. Genistein inhibits slow component delayed-rectifier K currents via a tyrosine kinase-independent pathway. J. Mol. Cell. Cardiol. 30 (1998) 2577-2590
41. Yang I.C., Cheng T.H., Wang F., Price E.M., and Hwang T.C. Modulation of CFTR chloride channels by calyculin A and genistein. Am. J. Physiol. 272 (1997) C142-155
42. Yu Z., Li W., and Liu F. Inhibition of proliferation and induction of apoptosis by genistein in colon cancer HT-29 cells. Cancer Lett. 215 (2004) 159-166